Unit of Psychiatry, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli.
Neuroradiology Unit, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia.
Personal Disord. 2023 Jul;14(4):452-466. doi: 10.1037/per0000621. Epub 2023 May 25.
Different psychotherapeutic approaches demonstrated their efficacy but the possible neurobiological mechanism underlying the effect of psychotherapy in borderline personality disorder (BPD) patients is poorly investigated. We assessed the effects of metacognitive interpersonal therapy (MIT) on BPD features and other dimensions compared to structured clinical management (SCM). We also assessed changes in amygdala activation by viewing emotional pictures after psychotherapy. One hundred forty-one patients were referred and 78 BPD outpatients were included and randomized to MIT or SCM. Primary outcome was emotional dysregulation assessed with the Difficulties in Emotion Regulation Scale (DERS). We also assessed BPD symptomatology, number of PD criteria, metacognitive abilities, state-psychopathology, depression, impulsiveness, interpersonal functioning, and alexithymia. A subset of 60 patients underwent functional magnetic resonance imaging before and after 1 year of psychotherapy to assess amygdala activation by viewing standardized emotional pictures (secondary outcome). DERS scores decreased in both groups (time effect < .001). The Cohen's effect size for change (baseline posttreatment) on DERS was very large ( = 0.84) in MIT, and large ( = 0.76) in SCM. Both groups significantly improved in depressive symptoms, state-psychopathology, alexithymia, and interpersonal functioning. MIT showed larger effect on metacognitive functions than SCM (Time × Group < .001). Both interventions showed a significant effect on BPD symptomatology although SCM group showed a larger decrease. On the contrary, MIT group showed larger decrease in impulsivity and number of PD criteria. Interestingly, both MIT and SCM modulated amygdala activation in BPD patients. MIT is a valid and effective psychotherapy for BPD with an impact on amygdala activation. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
不同的心理治疗方法已经证明了其疗效,但心理治疗对边缘型人格障碍(BPD)患者的可能神经生物学机制仍研究甚少。我们评估了元认知人际治疗(MIT)与结构化临床管理(SCM)相比,对 BPD 特征和其他维度的影响。我们还评估了心理治疗后观看情绪图片时杏仁核激活的变化。共有 141 名患者被转介,78 名 BPD 门诊患者入组并随机分配到 MIT 或 SCM 组。主要结局是使用情绪调节困难量表(DERS)评估情绪失调。我们还评估了 BPD 症状、人格障碍标准数量、元认知能力、状态精神病理学、抑郁、冲动、人际关系功能和述情障碍。60 名患者的亚组在心理治疗前和 1 年后进行了功能磁共振成像,以评估观看标准化情绪图片时杏仁核的激活(次要结局)。两组 DERS 评分均降低(时间效应<.001)。MIT 组变化的 Cohen's 效应量(基线后)非常大(=0.84),SCM 组较大(=0.76)。两组患者的抑郁症状、状态精神病理学、述情障碍和人际关系功能均显著改善。与 SCM 相比,MIT 对元认知功能的影响更大(时间×组<.001)。两种干预措施均对 BPD 症状有显著影响,尽管 SCM 组的降幅更大。相反,MIT 组的冲动和人格障碍标准数量下降更大。有趣的是,MIT 和 SCM 都能调节 BPD 患者的杏仁核激活。MIT 是 BPD 的一种有效和有效的心理治疗方法,对杏仁核激活有影响。(PsycInfo 数据库记录(c)2023 APA,保留所有权利)。